JPH0787757B2 - Highly stable liquid nutritional supplement - Google Patents
Highly stable liquid nutritional supplementInfo
- Publication number
- JPH0787757B2 JPH0787757B2 JP62191857A JP19185787A JPH0787757B2 JP H0787757 B2 JPH0787757 B2 JP H0787757B2 JP 62191857 A JP62191857 A JP 62191857A JP 19185787 A JP19185787 A JP 19185787A JP H0787757 B2 JPH0787757 B2 JP H0787757B2
- Authority
- JP
- Japan
- Prior art keywords
- dextrin
- fat
- nutritional supplement
- liquid nutritional
- highly stable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000007788 liquid Substances 0.000 title claims description 19
- 235000015872 dietary supplement Nutrition 0.000 title claims description 16
- 239000004375 Dextrin Substances 0.000 claims description 30
- 229920001353 Dextrin Polymers 0.000 claims description 30
- 235000019425 dextrin Nutrition 0.000 claims description 30
- 235000015097 nutrients Nutrition 0.000 claims description 11
- 230000001954 sterilising effect Effects 0.000 claims description 11
- 230000001804 emulsifying effect Effects 0.000 claims description 3
- 239000000047 product Substances 0.000 claims 1
- 239000003925 fat Substances 0.000 description 18
- 235000019197 fats Nutrition 0.000 description 18
- 239000000839 emulsion Substances 0.000 description 15
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 14
- 238000004659 sterilization and disinfection Methods 0.000 description 10
- 239000003549 soybean oil Substances 0.000 description 9
- 235000012424 soybean oil Nutrition 0.000 description 9
- 229910052757 nitrogen Inorganic materials 0.000 description 7
- 235000000346 sugar Nutrition 0.000 description 7
- 239000003995 emulsifying agent Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 150000004667 medium chain fatty acids Chemical class 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 229940013317 fish oils Drugs 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000000468 intravenous fat emulsion Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 239000002960 lipid emulsion Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000001819 pancreatic juice Anatomy 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Non-Alcoholic Beverages (AREA)
Description
【発明の詳細な説明】 産業上の利用分野 本発明は、投与に際して窒素源であるタンパク質、アミ
ノ酸、低分子ペプチドの各々単独もしくはその混合物を
含む栄養剤と併用するための、糖質源と脂肪源を含む液
状栄養剤に関する。Description: TECHNICAL FIELD The present invention relates to a carbohydrate source and a fat for use in combination with a nutritional supplement containing a nitrogen source protein, amino acid, and low molecular weight peptide alone or in a mixture thereof. A liquid nutritional supplement containing a source.
技術的背景 栄養剤は術前及び術後の栄養管理に広く用いられている
が、その際栄養剤の窒素源は、タンパク態と、アミノ酸
及び低分子ペプチドの二群に大別される。Technical background Nutrients are widely used for preoperative and postoperative nutritional management. At that time, the nitrogen sources of nutrients are roughly divided into protein group and amino acid and low molecular weight peptides.
そして、通常の病態下では上記窒素源はタンパク態で十
分であるが、極度の消化吸収障害が起つている場合、特
に膵液等が分泌されないような病態では、窒素源として
アミノ酸及び低分子ペプチドが吸収良好の故に好まし
い。And, under normal pathological conditions, the nitrogen source is sufficient in the protein state, but if extreme digestive and absorption disorders occur, especially in the pathological state where pancreatic juice and the like are not secreted, amino acids and low-molecular peptides as nitrogen sources are It is preferable because of good absorption.
而して、これら窒素源を含む栄養剤は、それを液状形態
にするとき、ピタミン類の劣化がみられ、また、アミノ
酸及び低分子ペプチドが窒素源である場合には糖質源と
しての還元糖との共存下で褐変現象(アミノカルボニル
反応又はメイラード反応)が生じ、更には乳化の不安定
性等の問題がみられる。Thus, in the nutrients containing these nitrogen sources, when they are made into a liquid form, the deterioration of pitamines is observed, and when amino acids and low molecular weight peptides are nitrogen sources, they are reduced as sugar sources. A browning phenomenon (aminocarbonyl reaction or Maillard reaction) occurs in the presence of sugar, and problems such as instability of emulsion are observed.
本発明者は、上記栄養剤の液状化にあたつての安定性に
ついて検討した結果、栄養剤を窒素源から成る部分と、
糖質及び脂肪から成る成分の二液にとなし、投与時に両
液を混合することにより、叙上の問題を解決し得ること
に着目し、糖質及び脂肪から成る部分の栄養剤について
は、糖質として一定以上のDEを示すデキストリンを用
い、かつデキストリンと脂肪をそれぞれ一定範囲の量を
含有させることにより、乳化安定性の高い液状形態のも
のが得られることが見出し、本発明をなすに至つた。The present inventor, as a result of studying the stability of the nutritional supplement during liquefaction, a nutritional supplement consisting of a nitrogen source,
Focusing on the fact that the above problem can be solved by mixing the two liquids at the time of administration with the two liquids of the components consisting of sugars and fats, regarding the nutritional supplement of the part consisting of sugars and fats, It has been found that a liquid form having high emulsion stability can be obtained by using a dextrin having a DE of a certain level or more as a carbohydrate, and containing dextrin and fat in an amount within a certain range, respectively. It arrived.
因に、一般に糖質源としては、その消化性が良いこと、
投与時に細い管を用いるため高粘度にならないこと及び
下痢防止すること、血中糖濃度の急激な上昇による高浸
透圧防止をすること等の観点から、デンプン、単糖類及
び二糖類等の糖質よりもデンプンを加水分解したデキス
トリンが優れていることが知られている。In general, as a sugar source, its digestibility is good,
Carbohydrates such as starch, monosaccharides, and disaccharides are used from the viewpoint of preventing high viscosity due to the use of a thin tube during administration, preventing diarrhea, and preventing hyperosmotic pressure due to a rapid increase in blood sugar concentration. It is known that dextrin obtained by hydrolyzing starch is superior to dextrin.
一方、脂肪源としては、必須脂肪酸であるリノール酸ま
たはω3系の高度不飽和脂肪酸の供給及び吸収性の観点
から大豆油、コーン油、ヤシ油、サフラワー油等の植物
油、魚油、または人工的に調製された中鎖脂肪酸トリグ
リセリド(MCT)が好ましいとされている。なお、この
栄養剤へは必要に応じ、脂溶性及びビタミンB1などの水
溶性ビタミン、更にはその種類、量などを限定すればミ
ネラルなども添加し得る。On the other hand, as a fat source, vegetable oils such as soybean oil, corn oil, coconut oil, and safflower oil, fish oils, or artificial oils from the viewpoint of supply and absorbability of linoleic acid which is an essential fatty acid or ω3 type highly unsaturated fatty acid. The medium-chain fatty acid triglyceride (MCT) prepared in 1. is said to be preferable. If necessary, fat-soluble and water-soluble vitamins such as vitamin B 1 and minerals can be added to the nutritional supplement if the kind and amount thereof are limited.
従来、医療に用いられる静注用脂肪乳剤は、脂肪として
大豆油を用い、これを、大豆又は卵より分離、精製した
高純度レシチンを乳化剤に用いて乳化し、かつ等張化剤
として濃グリセリンを加えて均質化した後、レトルト滅
菌して投与に供している。Conventionally, intravenous fat emulsions used in medicine use soybean oil as a fat, which is emulsified using high-purity lecithin separated and purified from soybean or egg as an emulsifier, and concentrated glycerin as an isotonicity agent. Is homogenized by adding and is sterilized by retort and then used for administration.
しかしながら、上記脂肪乳剤において、濃グリセリンに
代えてデキストリンを用いた場合には乳化安定性が悪
く、レトルト滅菌により乳剤は直ちに分離するため、従
来、脂肪とデキストリンとの混合液からは安定な乳化剤
は得られないとされていた。However, in the above fat emulsion, when dextrin is used in place of concentrated glycerin, the emulsion stability is poor, and the emulsion is immediately separated by retort sterilization. Therefore, conventionally, a stable emulsifier from a liquid mixture of fat and dextrin is It was said that he could not get it.
発明が解決しようとする課題 本発明は、叙上のごとく、栄養剤の糖質源として優れて
いるデキストリンを脂肪源と配合しても、滅菌処理及び
保存下において高い乳化安定性を示す液状栄養剤を提供
することを課題とする。DISCLOSURE OF THE INVENTION Problems to be Solved by the Invention As described above, the present invention provides a liquid nutrition that exhibits high emulsion stability under sterilization and storage even when dextrin, which is excellent as a sugar source for nutritional supplements, is mixed with a fat source. It is an object to provide an agent.
以下本発明を詳しく説明する。The present invention will be described in detail below.
発明の構成 本発明の構成上の特徴は、DEが25以上のデキストリン10
〜20%(W/V)と脂肪2.5〜10%(W/V)を含み、かつデ
キストリンと脂肪の合計量が15〜25%(W/V)である栄
養剤を乳化させ、滅菌して成る安定性の高い液状栄養剤
にある。Structure of the Invention The structural feature of the present invention is that dextrin 10 having a DE of 25 or more is used.
~ 20% (W / V) and 2.5-10% fat (W / V), and the total amount of dextrin and fat is 15-25% (W / V), emulsify and sterilize It is a highly stable liquid nutritional supplement.
課題を解決するための手段 デキストリンと脂肪を含む液状栄養剤の乳化性を、その
滅菌及び保存下において安定に保持するには、デキスト
リンと脂肪の濃度及びデキストリンのDEの選定が重要で
ある。Means for Solving the Problems In order to stably maintain the emulsifiability of a liquid nutrient containing dextrin and fat under sterilization and storage thereof, it is important to select the concentration of dextrin and fat and the DE of dextrin.
すなわち、本発明で用いるデキストリンは、DEが25以上
であることが肝要であつて、DEが25より低いデキストリ
ンでは、レトルト滅菌及び1ヶ月間の保存において乳化
状態が分離される。That is, it is essential that the dextrin used in the present invention has a DE of 25 or more, and with a dextrin having a DE of less than 25, the emulsified state is separated during retort sterilization and storage for 1 month.
また、デキストリンと脂肪との濃度は、デキストリンで
は10〜20%(W/V)、脂肪では2.5〜10%(W/V)の範囲
にあること、及びデキストリンと脂肪の合計量が15〜25
%(W/V)の範囲にあることが肝要である。The concentration of dextrin and fat is in the range of 10 to 20% (W / V) for dextrin and 2.5 to 10% (W / V) for fat, and the total amount of dextrin and fat is 15 to 25%.
It is important to be in the range of% (W / V).
次に、デキストリンとしてDE−33のデキストリンを、脂
肪として大豆油をそれぞれ用い、デキストリンを10%〜
28%(W/V)を、大豆油を1.5〜10%(W/V)の各濃度
で、両者を合計量で15%〜34.5%(W/V)になるように
組合わせて表1に示す組成の液状栄養剤を調製し、レト
ルト殺菌後並びに37℃に6ヶ月保存後の乳化安定性を調
べた。なお、液状栄養剤の乳化は乳化剤を用い、均質機
にて500kg/cm2で3回均質化を行つた。また、レトルト
殺菌は、栄養剤をガラスビンに充填し、121℃の温度に1
5分間行つた。Next, DE-33 dextrin was used as the dextrin, and soybean oil was used as the fat.
28% (W / V), soybean oil at each concentration of 1.5-10% (W / V), combined so that the total amount becomes 15% -34.5% (W / V) Table 1 A liquid nutrient having the composition shown in (1) was prepared, and the emulsion stability after retort sterilization and after storage at 37 ° C. for 6 months was examined. The liquid nutrient was emulsified using an emulsifier and homogenized three times at 500 kg / cm 2 with a homogenizer. Also, for retort sterilization, fill the glass bottle with the nutritional supplement and
I went for 5 minutes.
結果は表1に示すとおりである。The results are shown in Table 1.
表1にみられるとおり、デキストリンが10%〜20%(W/
V)の濃度、大豆油が2.5〜10%(W/V)の濃度及びデキ
ストリンと大豆油の合計固形分量が15%〜25%の範囲で
は、レトルト滅菌後、6ヶ月保存下でも乳化が安定して
いることが認められる。 As seen in Table 1, dextrin is 10% to 20% (W /
V) concentration, soybean oil 2.5 to 10% (W / V) concentration, and total solid content of dextrin and soybean oil in the range of 15% to 25%, emulsion is stable even after storage for 6 months after retort sterilization. It is recognized that they are doing.
次に、デキストリンのDEを種々変えた場合における栄養
剤の安定性に与える影響を下記により調べた。Next, the influence of various dextrin DEs on the stability of the nutritional supplement was investigated by the following.
デキストリンとして、表2に示す種々のDEのものをそれ
ぞれ15%(W/V)濃度で、脂肪として大豆油を10%(W/
V)濃度で用い、乳化剤を加えて均質機にて500kg/cm2で
3回均質化したものをガラスビンに充填し、121℃の温
度に15分間レトルト滅菌を行つた後、さらに37℃に1ヶ
月保存した。As the dextrin, various DEs shown in Table 2 were used at a concentration of 15% (W / V), and soybean oil was used as a fat at 10% (W / V).
V) Concentrate, add an emulsifier and homogenize 3 times with a homogenizer at 500 kg / cm 2 into a glass bottle, perform retort sterilization at a temperature of 121 ° C for 15 minutes, and then to 1 ° C at 37 ° C. Stored for a month.
結果は表2に示すとおりである。The results are shown in Table 2.
表2にみられるように、DEが25以上のデキストリンでは
滅菌後、1ヶ月保存しても乳化性が保持されていたが、
DEが19以下では乳化性は不安定であつて保持されない。 As shown in Table 2, with dextrin having a DE of 25 or more, the emulsifiability was retained even after storage for 1 month after sterilization.
When DE is 19 or less, the emulsifying property is unstable and cannot be maintained.
以上述べたとおり、本発明に従つて一定以上のDEを有す
るデキストリンと脂肪を特定な範囲の濃度で乳化するこ
とにより、レトルト殺菌及びその後の長期保存下におい
ても乳化安定性の高い液状栄養剤を提供できるので、本
発明は、滅菌液状栄養剤として実用に供することができ
る。As described above, by emulsifying dextrin and fat having a certain DE or more according to the present invention in a concentration in a specific range, a liquid nutrient with high emulsion stability even under retort sterilization and subsequent long-term storage. Since it can be provided, the present invention can be put to practical use as a sterile liquid nutritional supplement.
以下に実施例を示して本発明に依る液状栄養剤の調製法
を具体的に説明する。Hereinafter, the method for preparing the liquid nutritional supplement according to the present invention will be specifically described with reference to examples.
実施例1 精製大豆油140kgに乳化剤を添加し、70℃の温度で加熱
溶解した。この溶液を、予め水2800にDE33のデキスト
リン700kgを加えて溶解させておいた溶液に加え、更に
水を加え全量を3750に調整し70℃の温度の加熱下にホ
モミキサーにより予備乳化を行つた。次いで、この乳化
液を更に高圧均質機を用いて500kg/cm2で3回繰返し乳
化を行つた。得られた均質乳化液をガラスビンに充填
し、121℃の温度で15分間レトルト殺菌を行つて、目的
の液状栄養剤を得た。Example 1 To 140 kg of refined soybean oil, an emulsifier was added and dissolved by heating at a temperature of 70 ° C. This solution was added to a solution prepared by previously adding 700 kg of dextrin of DE33 to 2800 water and dissolving it, and further adding water to adjust the total amount to 3750, and preliminarily emulsified with a homomixer under heating at a temperature of 70 ° C. . Then, this emulsion was further emulsified three times at 500 kg / cm 2 using a high-pressure homogenizer. The obtained homogeneous emulsion was filled in a glass bottle and retort sterilized at a temperature of 121 ° C. for 15 minutes to obtain a target liquid nutrient.
得られた栄養剤を37℃で6ヶ月保存したが、離水や油分
離は認められず、乳化安定性は良好であつた。The obtained nutritional supplement was stored at 37 ° C for 6 months, but no water separation or oil separation was observed and the emulsion stability was good.
実施例2 中鎖脂肪酸トリグリセリド98kgと精製大豆油42kgの混合
油に乳化剤を加えて70℃に加熱して溶解した。この溶液
を、予め水2800にDE44のデキストリン700kgを加えて
溶解した液に加え、更に水を加え全量を3750に調整し
70℃の温度下にホモミキサーで予備乳化を行つた。Example 2 An emulsifier was added to a mixed oil of 98 kg of medium chain fatty acid triglyceride and 42 kg of refined soybean oil, and the mixture was heated to 70 ° C. and dissolved. This solution was added to a solution prepared by adding 700 kg of DE44 dextrin to 2800 water in advance and further adding water to adjust the total amount to 3750.
Pre-emulsification was performed with a homomixer at a temperature of 70 ° C.
次いで、この乳化液を更に高圧均質機を用いて500kg/cm
2で3回繰返して乳化を行つた。得られた均質乳化液を
ガラスビンに充填し、121℃で15分間レトルト滅菌を行
つて、液状栄養剤を得た。Then, this emulsion was further subjected to a high pressure homogenizer at 500 kg / cm.
The emulsion was emulsified by repeating 2 times 3 times. The obtained homogeneous emulsion was filled in a glass bottle and retort sterilized at 121 ° C. for 15 minutes to obtain a liquid nutrient.
得られた栄養剤を37℃で6ヶ月保存したが離水や油分離
は認められず、乳化安定性は良好であつた。The obtained nutrient was stored at 37 ° C. for 6 months, but no water separation or oil separation was observed and the emulsion stability was good.
Claims (1)
剤において、DEが25以上のデキストリン10〜20%(W/
V)と脂肪2.5〜10%(W/V)を含み、かつデキストリン
と脂肪の合計量が15〜25%(W/V)である栄養剤を乳化
剤で乳化させ、滅菌して成る高い安定性の液状栄養剤。1. A liquid nutritional supplement containing dextrin and fat, wherein dextrin having a DE of 25 or more is 10 to 20% (W /
V) and 2.5 to 10% (W / V) fat, and the total amount of dextrin and fat is 15 to 25% (W / V), a highly stable product obtained by emulsifying and sterilizing a nutrient. Liquid nutritional supplement.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP62191857A JPH0787757B2 (en) | 1987-07-31 | 1987-07-31 | Highly stable liquid nutritional supplement |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP62191857A JPH0787757B2 (en) | 1987-07-31 | 1987-07-31 | Highly stable liquid nutritional supplement |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6434271A JPS6434271A (en) | 1989-02-03 |
| JPH0787757B2 true JPH0787757B2 (en) | 1995-09-27 |
Family
ID=16281658
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP62191857A Expired - Lifetime JPH0787757B2 (en) | 1987-07-31 | 1987-07-31 | Highly stable liquid nutritional supplement |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0787757B2 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4740214B2 (en) * | 1997-11-14 | 2011-08-03 | ロンシール工業株式会社 | WELDING AGENT, ADHESIVE, SEALING AGENT AND DEFECT DETECTION DETECTING METHOD USED FOR DETECT DETECTION METHOD |
| JP6098047B2 (en) * | 2012-06-27 | 2017-03-22 | 日油株式会社 | Liquid nutrition composition |
| JP6083962B2 (en) * | 2012-06-27 | 2017-02-22 | 日油株式会社 | Acid-resistant liquid nutritional composition |
-
1987
- 1987-07-31 JP JP62191857A patent/JPH0787757B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6434271A (en) | 1989-02-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5723446A (en) | Enteral formulation designed for optimized nutrient absorption and wound healing | |
| DE60119919T2 (en) | FREE AMINOIC COMPOSITION | |
| AU666246B2 (en) | Nutritional product for persons having a neurological injury | |
| CN102348469B (en) | OMEGA-3 Rich Fish Oil in Water Non-Oral Nutritional Emulsion | |
| DE69936391T2 (en) | ENTERALES FOODS CONTAINING HYDROLYZED SOY PROTEIN AND PARTLY HYDROLYZED CASEINATE | |
| KR860001774B1 (en) | Manufacturing method of oil-in-water emulsion for nutrition | |
| EP0764405A2 (en) | Nutritional composition | |
| JPS6236645B2 (en) | ||
| EP0189161A2 (en) | Enteral nutritional hypoallergenic formula | |
| CA2407198A1 (en) | Shelf stable nutritional composition containing intact whey protein, process of manufacture and use | |
| NO142505B (en) | PROCEDURE FOR PREPARING AN OIL-IN-WATER EMULSION FOR PARENTERAL INJECTION | |
| EP0265772A2 (en) | Liquid nutritional formula for glucose intolerance | |
| EP0220152A1 (en) | Fat emulsion | |
| JPS5948414A (en) | Water-soluble preparation of vitamin e | |
| JPH0747544B2 (en) | O / W emulsion nutritional composition | |
| JPH0787757B2 (en) | Highly stable liquid nutritional supplement | |
| JPH08169824A (en) | Lipid emulsion for pediatrics | |
| JPS63297342A (en) | Synthetic oil or fat and fatty emulsion infusion solution and tube feeding agent containing said oil or fat | |
| JPH0394660A (en) | Powdery nutrition composition | |
| JPH09157179A (en) | Liquid nourishing composition | |
| JPH02142448A (en) | Sterilized liquid nutritive agent | |
| JP2824598B2 (en) | Nutrition composition | |
| JPS6342510B2 (en) | ||
| JPS61135572A (en) | Fat emulsion for intestinal use | |
| JPH10139681A (en) | Aqueous emulsified nutritional composition and its use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EXPY | Cancellation because of completion of term |